Trading Update March 2010
Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of specialist diagnostic testing kits for the clinical and research markets is pleased to provide a trading update for the financial year ending 31 March 2010.
Turnover for the year ending 31 March 2010 is expected to be £37,1m, circa 49% ahead of last year’s performance (fy/e 31 March 2009: £24.9m) and trading in all of the Group’s main territories has increased year on year. Sales into the USA, France, Germany and the UK have grown significantly this year. Profits before tax for the year ending 31 March 2010 are expected to be in line with the Board’s expectations.